p53 dysfunction in chronic lymphocytic leukemia

POSPÍŠILOVÁ, Šárka and Andrew PETTITT. p53 dysfunction in chronic lymphocytic leukemia. In K. Stamatopoulos, P. Ghia, R. Rosenquist. New Biological Prognostic Markers in Chronic Lymphocytic Leukemia. Milano: Wolters Kluwer Helath Italy Ltd, 2010, p. 73-95. ISBN 978-88-7556-551-0.

Basic information

Original name

p53 dysfunction in chronic lymphocytic leukemia

Authors

POSPÍŠILOVÁ, Šárka (203 Czech Republic, guarantor, belonging to the institution) and Andrew PETTITT (826 United Kingdom of Great Britain and Northern Ireland)

Edition

Milano, New Biological Prognostic Markers in Chronic Lymphocytic Leukemia, p. 73-95, 23 pp. 2010

Publisher

Wolters Kluwer Helath Italy Ltd

---

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Italy

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

RIV identification code

RIV/00216224:14110/10:00059308

Organization unit

Faculty of Medicine

ISBN

978-88-7556-551-0

Keywords in English

lymphocytic leukemia; tumor suppressor; p53

Tags

ok, rivok

Tags

International impact, Reviewed

---

Abstract

V originále

The p53 protein plays a key role in protecting cells against malignant transformation by preventing the accumulation of genomic alterations and is probably the most extensively studied protein.